pharma
Arpida A/S
Arpida A/S patent portfolio — 4 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.
Company details
- Status
- Public
- HQ
- EU
- Programs
- 0
- Drugs
- 0
- Patents
- 4
Arpida A/S patents
4 pharmaceutical patents indexed for Arpida A/S. 0 expire within 24 months.
Arpida A/S has 4 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.
Patent portfolio
-
WO 2005105843
INHIBITEURS DE VIH PROTEASE
expired -
WO 2005092872
INHIBITEURS DE PEPTIDE DEFORMYLASE
expired -
WO 2005037272
DERIVES DE BENZIMIDAZOLE ET LEUR APPLICATION COMME INHIBITEURS DE LA PEPTIDE-DEFORMYLASE
expired -
WO 2005026133
ISOXAZOLES UTILISES COMME INHIBITEURS DE PEPTIDE DEFORMALYSE
expired
Frequently asked questions
How many patents does Arpida A/S have?
4 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).
When do Arpida A/S patents expire?
0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.